Medical News

RSS

Hydrogen-powered shipping could deliver $284 billion in annual health benefits

Researchers modeled how replacing conventional global shipping fuels with hydrogen could change PM2.5 and ozone pollution, premature mortality, and monetized health benefits. Under complete transition, the model estimated 129,458 fewer premature deaths and US$284 billion in annual monetized health benefits, although some regions experienced increased pollution from hydrogen production or altered ozone chemistry.

31 Jul 2026

Research identifies common neuroimmune signatures in rapid-acting antidepressants

In a new study, researchers from The University of Texas MD Anderson Cancer Center have uncovered insights that may help explain how rapid-acting antidepressants, such as ketamine and psychedelics, can reduce symptoms in difficult-to-treat depression.

30 Jul 2026

Coastal residents more likely to have worse midlife health

People who live by the coast in midlife are more likely to have worse health, finds a new study in England and Wales led by UCL researchers.

30 Jul 2026

University of Exeter launches ADHD toolkit for UK primary schools

A new ADHD toolkit from the University of Exeter is the first of its kind designed specifically to be used in UK primary schools.

30 Jul 2026

Program introduces Florida students to virology and pandemic preparedness

Thirty outstanding high school students from 18 communities across Florida arrived in Tampa last week for the Global Virus Network (GVN) Global Guardians for Pandemic Preparedness Program, curious about viruses and considering careers in science.

30 Jul 2026

NIH funds UVA research to develop advanced laboratory tissue models

A University of Virginia researcher has received a five-year, $2.1 million National Institutes of Health grant to develop advanced laboratory tissue models that could improve drug testing, deepen scientists' understanding of disease and reduce the need for animal testing.

30 Jul 2026

Ten-million-person study links semaglutide to lower COVID-19 mortality

Researchers analyzing claims from more than 10.1 million commercial insurance and Medicare Advantage enrollees found that semaglutide use was associated with a 49% lower adjusted hazard of COVID-19-related death. The observational findings corroborate earlier SELECT trial results but do not establish causation, making further prospective research essential.

30 Jul 2026

QUANTUM trial tests immune-targeting approach for primary plasma cell leukemia

The Alliance for Clinical Trials in Oncology today announced the activation of The QUANTUM Trial (Alliance A062401), a clinical study designed to test a novel, immune-targeting approach for patients newly diagnosed with primary plasma cell leukemia (PCL).

30 Jul 2026

Insilico unveils standardized evaluation framework to validate AI-driven drug discovery models

As general-purpose and domain-specific AI models rapidly infiltrate drug discovery, one critical question looms over the pharmaceutical sector: Can these models actually discover drugs, or are they just good at taking tests?

30 Jul 2026

New NYU Langone facility expands specialty healthcare access in Brooklyn

NYU Langone Health is continuing to expand its footprint in Brooklyn with the opening of NYU Langone Ambulatory Care—Fort Hamilton, a new multispecialty practice offering top-quality care.

30 Jul 2026

Flexible sensing-memory integrated platform advances physiological health monitoring

A wearable health monitoring system that achieves seamless integration of sensing and memory functions is of great significance for real-time physiological signal acquisition and processing.

30 Jul 2026

Pork supply chains may be shaping the global spread of drug-resistant Salmonella

Researchers linked 129,136 global human and swine Salmonella genomes with sampling from a Guangdong pork supply chain to examine how downstream stages relate to antimicrobial resistance. The study suggests slaughterhouse and retail interfaces may concentrate S. 4,[5],12:i:- ST34, resistant strains, and mobile resistance elements, supporting broader One Health surveillance beyond farms.

30 Jul 2026

Study reveals widening inequality in leisure-time physical activity

A ten-year study of residents of the city of São Paulo, Brazil, revealed that leisure-time physical activity is highly unequal and that the gap between social strata is widening.

30 Jul 2026

Biotherapeutic metabolite repairs gut damage caused by HIV infection

Researchers at the UC Davis School of Medicine have identified a naturally occurring metabolite that repairs gut damage caused by HIV infection and significantly improves the effectiveness of antiretroviral therapy (ART) in the nonhuman primate model of HIV/AIDS.

30 Jul 2026

Microbial metabolites could help improve functional cure rates for hepatitis B

Chronic hepatitis B (CHB) remains a major global challenge. Current therapies suppress HBV but rarely achieve functional cure (sustained HBsAg loss).

30 Jul 2026

Common allergy medications offer no real relief for eczema patients

It's typical for someone looking for relief from dry, itchy, red and irritated skin – also known as eczema or atopic dermatitis – to turn to common allergy medications called antihistamines.

30 Jul 2026

New computational technique traces ghost ancestry in modern human genomes

UC Berkeley researchers have identified regions of DNA that humans inherited from two unknown ancestors as a result of long-ago interbreeding among modern humans and at least four other archaic human relatives.

30 Jul 2026

Differing priorities create barriers to AI adoption in older adult healthcare

While artificial intelligence (AI) holds immense promise for transforming health care for older adults, a new study published in JMIR Aging reveals significant friction between those who use AI health tools and those who create and fund them.

30 Jul 2026

Dual immunotherapy with neoadjuvant chemotherapy shows encouraging activity in ERBB2-negative breast cancer

A combination of two immunotherapy drugs showed encouraging activity when added to standard chemotherapy given prior to surgery for patients with high-risk, early-stage HER2-negative breast cancer, according to phase 2 clinical trial results from the ongoing I-SPY2 clinical trial platform.

30 Jul 2026

New OpenABE gene editor improves editing efficiency by up to 36 times

A joint research team led by Professor Daesik Kim (Department of Medicine, Sungkyunkwan University), along with Professor Yong-Sub Kim (University of Ulsan College of Medicine) and Professor Jae-Hyun Park (Sungkyunkwan University School of Medicine), has announced the development of 'OpenABE' (Open Adenine Base Editor).

30 Jul 2026